New Zolgensma Clinical Trial
A new clinical trial is starting for gene therapy for patients aged 3 months - 20 years old who are: Symptomatic SMA diagnosis based on gene mutation analysis with bi-allelic survival motor neuron 1 (SMN1) mutations (deletion or point mutations)…